Also trades as: CL.CN (CNQ) · $vol 0M
CRLBF OTC
Cresco Labs Inc.
1W: -12.9%
1M: -15.9%
3M: -15.6%
YTD: -48.4%
1Y: -53.6%
3Y: -65.4%
5Y: -93.0%
$0.65
-0.01 (-1.52%)
Weekly Expected Move ±9.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.00
Neutral
1 bullish
1 neutral
1 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (35)
2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors
Cannabis stocks sink after DEA marijuana rescheduling hearing paused
DEA marijuana rescheduling hearing halted over GAO report
Federal court allows Trump administration marijuana rescheduling to proceed
Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?
Cresco Labs to buy nine Pennsylvania dispensaries in $48M deal
Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates
GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
Green Thumb Industries: Marijuana Meme Stock or Dream Stock?
State AGs challenge Trump admin medical marijuana shift
Is Green Thumb Becoming the "Procter & Gamble of Cannabis"?
Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates
Cresco Labs reports Q1 results
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates
Why Trump didn't really 'legalize it'
Cannabis MSOs to see increased investment, lower taxes from reclassification
Quant snapshot on cannabis names as Trump plans reclassification
Top AdvisorShares Pure US Cannabis ETF Holdings ranked by Quant as Federal rescheduling advances
Marijuana MSOs surge on report Trump set to formally reclassify cannabis
Cannabis Operator GTBIF Stock Down 17% YTD: Should You Buy the Dip?
Should Cresco Stock Be in Your Portfolio Post Q4 Earnings?
Cresco Labs Inc. (CRLBF) Reports Q4 Loss, Beats Revenue Estimates
Cannabis Stock VRNO Rises 40% in a Year: Time to Buy, Sell or Hold?
Cresco Labs reports Q4 results
Here are the major earnings before the open Thursday
What to Expect from Cresco Labs's Earnings
Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026
Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida
Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry
These Marijuana Stocks Could Make You Money In 2026
Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?